Depression (Major/Severe) Clinical Trials

A listing of Depression (Major/Severe) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arkansas

Research Site
Little Rock Arkansas 72211

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Woodland International Research Group, INC
Little Rock Arkansas 72211

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

California

UPDATED

Pacific Clinical Research Medical Group
Upland California 91786

Clinical trial for Depression, MDD

Comprehensive Neuroscience Inc.
Cerritos California 90703

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

ProScience Research Group
Culver City California 90230

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Pharmacology Research Institute, Encino
Encino California 91316

A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study with Levomilnacipran ER in Patients with Major Depressive Disorder

Research Site
Garden Grove California 92845

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

California Clinical Trials
Glendale California 91206

Outpatient study for an investigational medication for depression

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 12-week, randomized, double-blind, controlled evaluation followed by an open-label 12-week follow-up period of the impact of GeneSight Psychotropic on response to psychotropic treatment in outpatients suffering from a major depressive disorder (MDD) and having had- with the current episode- an inadequate response to at east one psychotropic medication included in GeneSight Psychotropic.

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-3 Study)

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Double-Blind, Placebo-Controlled, Randomized, Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients with Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Current Antidepressant Therapy

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder

Pharmacology Research Institute
Newport Beach California 92660

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Artemis Institute for Clinical Research
San Diego California 92103

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

California Neuroscience Research Medical Group, Inc.
Sherman Oaks California 91403

Clinical research study of an investigational drug vs. placebo in persons with Major Depression.

California Neuroscience Research Medical Group, Inc.
Sherman Oaks California 91403

Clinical research study of an investigational medication vs. placebo added to a standard antidepressant treatment in persons with Major Depression.

Schuster Medical Research Institute
Sherman Oaks California 91403

Do you or someone you care about suffer from Major Depressive Disorder?

Stanford University
Stanford California 94304

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Viking Clinical Research Center
Temecula California 92591

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Pacific Clinical Research Medical Group
Upland California 91786

Being a Kid is Hard Enough without having to deal with DEPRESSION

Connecticut

Yale Depression Research Program/ Clinical Neuroscience Research Unit Connecticut Mental Health Center
New Haven Connecticut 06511

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Yale University
New Haven Connecticut 06511

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Florida

Florida Clinical Research Center - Bradenton/Sarasota
Bradenton Florida 34201

Are you struggling with depression? Have you taken an antidepressant but still feel low, lack interest in life, sleep badly, and feel tired every day?

CNS Clinical Research Group
Coral Springs Florida 33067

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

MD Clinical
Hallandale Beach Florida 33009

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Innovative Clinical Research, Inc.
Lauderhill Florida 33319

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Segal Institute for Clinical Research - Innovative Clinical Research, Inc.
Lauderhill Florida 33319

Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD).

Compass Research, LLC
Leesburg Florida 34748

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Innova Clinical Trials Inc.
Miami Florida 33145

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Scientific Clinical Research, Inc.
North Miami Florida 33161

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Segal Institute for Clinical Research - Behavioral Clinical Research, Inc.
North Miami Florida 33161

Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD).

Research Centers of America LLC
Oakland Park Florida 33334

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Advanced Psychiatric Group, PA
Orlando Florida 32803

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

University of South Florida- Department of Psychiatry and Behavioral Neurosciences
Tampa Florida 33613

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder (MDD)

Georgia

Emory University
Atlanta Georgia 30322

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Atlanta Center for Medical Research
Atlanta Georgia 30331

Major depressive disorder, including suicidal ideation

Northwest Behavioral Research Center
Marietta Georgia 30060

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Illinois

Rush University Medical Center
Chicago Illinois 60612

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Rush University Medical Center
Chicago Illinois 60612

Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)

Alexian Brothers Hospital Network
Hoffman Estates Illinois 60169

A multicenter, randomized, double-blind study to evaluate the efficacy, safety and tolerability of an oral Aripiprazole-Escitalopram combination therapy in patients with Major Depressive Disorder.

Alexian Brothers Hospital Network
Hoffman Estates Illinois 60169

A multicenter, randomized, double-blind, parallel group, placebo controlled, phase III, efficacy and safety study of 3 fixed dose groups of TC-5214 (S-mecamylamine) as an adjunct to an antidepressant in patients with Major Depressive Disorder who exhibit an inadequate resopnse to antidepressant therapy.

Alexian Brothers Hospital Network
Hoffman Estates Illinois 60169

A phase 3, randomized, double blind, parallel group, placebo-controlled, fixed dose study comparing the efficacy and safety of 2 doses (10 and 15mg) of Lu AA21004 in acute treatment of adults with major depressive disorder.